Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
TriSalus Life Sciences, Inc. (TLSI) had Debt to Equity Ratio of -1.66 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$11.21M |
|
$-9.00M |
|
$1.80M |
|
$9.41M |
|
$18.55M |
|
$-7.33M |
|
$-0.96M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-7.33M |
|
$-6.91M |
|
32.90M |
|
32.90M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$38.08M |
|
$1.71M |
|
$3.23M |
|
$41.32M |
|
$9.32M |
|
$32.27M |
|
$51.42M |
|
$60.74M |
|
$-19.42M |
|
$-19.42M |
|
$-19.42M |
|
37.98M |
|
| Cash Flow Statement Financials | |
$-11.82M |
|
$-0.62M |
|
$30.41M |
|
$8.88M |
|
$26.84M |
|
$17.96M |
|
$3.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.08 |
|
-- |
|
-- |
|
2.51 |
|
|
Debt to Equity Ratio |
-1.66 |
83.93% |
|
-65.39% |
|
-65.39% |
|
-- |
|
-73.94% |
|
-80.28% |
|
$-12.44M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.47 |
|
2.01 |
|
44.72 |
|
42.70% |
|
42.70% |
|
-20.07% |
|
-64.54% |
|
$-0.51 |
|
$-0.38 |
|
$-0.36 |
|